Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Market Insights | Japan | 2024

The Japanese PV device market will continue to experience modest growth through 2032 primarily due to growth in the endovascular procedure volumes along with the rising adoption of premium-priced devices such as DCBs and DES. However, revenue growth will be limited to some extent due to ASP declines caused by MHLW biennial reimbursement cuts over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Japan from 2019 through 2032.

Related Medtech Insights Reports

Report
Sports Medicine Devices – Market Insights – Japan
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, improved surgeon training, and high levels of sports participation will…
Report
Large-Joint Reconstructive Implants – Market Insights – Japan
Growth in large-joint reconstructive procedure volumes is being driven by favorable demographic trends and increased demand for innovative technologies. However, market expansion is partly…
Report
Trauma Devices – Market Insights – Japan
The Japanese trauma device market will experience marginal growth through 2034, primarily fueled by the adoption of innovative, premium-priced technologies. This upward trend is further supported…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will experience moderate growth through 2034. This update reflects the impact of recent developments, including the launch of new-generation devices and…